1. Home
  2. LEXX vs TNMG Comparison

LEXX vs TNMG Comparison

Compare LEXX & TNMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • TNMG
  • Stock Information
  • Founded
  • LEXX 2004
  • TNMG 2023
  • Country
  • LEXX Canada
  • TNMG Japan
  • Employees
  • LEXX N/A
  • TNMG N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • TNMG
  • Sector
  • LEXX Health Care
  • TNMG
  • Exchange
  • LEXX Nasdaq
  • TNMG NYSE
  • Market Cap
  • LEXX 19.6M
  • TNMG 20.1M
  • IPO Year
  • LEXX N/A
  • TNMG N/A
  • Fundamental
  • Price
  • LEXX $0.83
  • TNMG $0.51
  • Analyst Decision
  • LEXX Strong Buy
  • TNMG
  • Analyst Count
  • LEXX 1
  • TNMG 0
  • Target Price
  • LEXX $7.00
  • TNMG N/A
  • AVG Volume (30 Days)
  • LEXX 146.6K
  • TNMG 514.2K
  • Earning Date
  • LEXX 07-11-2025
  • TNMG 08-01-2025
  • Dividend Yield
  • LEXX N/A
  • TNMG N/A
  • EPS Growth
  • LEXX N/A
  • TNMG N/A
  • EPS
  • LEXX N/A
  • TNMG N/A
  • Revenue
  • LEXX $525,923.00
  • TNMG $48,493,897.00
  • Revenue This Year
  • LEXX $0.62
  • TNMG N/A
  • Revenue Next Year
  • LEXX $14.19
  • TNMG N/A
  • P/E Ratio
  • LEXX N/A
  • TNMG N/A
  • Revenue Growth
  • LEXX 29.95
  • TNMG 35.31
  • 52 Week Low
  • LEXX $0.82
  • TNMG $0.26
  • 52 Week High
  • LEXX $4.38
  • TNMG $34.08
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 31.77
  • TNMG N/A
  • Support Level
  • LEXX $0.93
  • TNMG N/A
  • Resistance Level
  • LEXX $1.05
  • TNMG N/A
  • Average True Range (ATR)
  • LEXX 0.07
  • TNMG 0.00
  • MACD
  • LEXX -0.00
  • TNMG 0.00
  • Stochastic Oscillator
  • LEXX 14.14
  • TNMG 0.00

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About TNMG TNL MEDIAGENE

TNL Mediagene is principally engaged in digital advertising, integrated marketing, marketing survey, artificial intelligence technology, data analysis, content service platform and production of audio-visual programs. Geographically, the company generates the majority of its revenue from Taiwan.

Share on Social Networks: